Pharma Equity Group A/S: Financial statements 2017
CVR: 26791413
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -4,077,000 compared with DKK -2,015,000 the year before. Equity in the 2017 report amounted to DKK 103,285,000. The solvency ratio was 82.7%.
- Profit/Loss
- DKK -4,077,000
- Equity
- DKK 103,285,000
- Total Assets
- DKK 124,864,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -4.1 mio. | 103.3 mio. | - |
| 2016 | - | - | -2 mio. | 96.8 mio. | - |
| 2015 | - | - | -3.7 mio. | 99.5 mio. | - |
| 2014 | 0 | 0 | -5.9 mio. | 98 mio. | - |
Official annual report
Keep an eye on Pharma Equity Group A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Pharma Equity Group A/S has published its interim report for the period January 1, 2017 – June 30, 2017.
As of October 25, 2017, Claus Abildstrøm has joined the board of directors of Pharma Equity Group A/S.
As of October 25, 2017, Niels Troen has joined the board of directors of Pharma Equity Group A/S.
As of October 25, 2017, Niels Troen is registered as adm. dir. of Pharma Equity Group A/S.
As of October 25, 2017, Niels Troen has stepped down as adm. dir. of Pharma Equity Group A/S.
As of October 24, 2017, Claus Abildstrøm has left the board of directors of Pharma Equity Group A/S.
As of October 24, 2017, Niels Troen has left the board of directors of Pharma Equity Group A/S.
As of August 16, 2017, Peer Henning Borg is registered as adm. dir. of Pharma Equity Group A/S.
As of August 16, 2017, Peer Henning Borg has stepped down as adm. dir. of Pharma Equity Group A/S.
Pharma Equity Group A/S has published its annual report for 2016. The net result was DKK -2,015,000.
About Pharma Equity Group A/S
Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.